Interleukin-6 and diabetes: the good, the bad, or the indifferent?
about
Getting 'Smad' about obesity and diabetesMicroRNA-Regulated Proinflammatory Cytokines in SarcopeniaEndocrine causes of nonalcoholic fatty liver diseaseSkeletal muscle as an endocrine organ: PGC-1α, myokines and exerciseThe central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetesThe outliers become a stampede as immunometabolism reaches a tipping pointThe alliance of mesenchymal stem cells, bone, and diabetesConsiderations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 DiabetesMelanocortins induce interleukin 6 gene expression and secretion through melanocortin receptors 2 and 5 in 3T3-L1 adipocytesSedentary time and markers of chronic low-grade inflammation in a high risk populationAssociation between the interleukin-6 promoter polymorphism -174G/C and serum lipoprotein(a) concentrations in humansEffects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseasesCirculating levels of IL-1B+IL-6 cause ER stress and dysfunction in islets from prediabetic male mice.Heterogeneity of altered cytokine levels across the clinical spectrum of diabetes in China.Interacting epidemics? Sleep curtailment, insulin resistance, and obesity.The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index.Smartphone instrument for portable enzyme-linked immunosorbent assays.Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 daysInflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA).In vivo immune signatures of healthy human pregnancy: Inherently inflammatory or anti-inflammatory?Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS.Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic isletsGenetic polymorphisms of cytokine genes in type 2 diabetes mellitus.IL-6 in diabetes and cardiovascular complications.Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes.Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes.Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.High-level transient expression of ER-targeted human interleukin 6 in Nicotiana benthamianaMicrospectroscopic SERS detection of interleukin-6 with rationally designed gold/silver nanoshells.Population differences in proinflammatory biology: Japanese have healthier profiles than Americans.Genistein modulation of streptozotocin diabetes in male B6C3F1 mice can be induced by dietType 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes.Primary vitamin D target genes allow a categorization of possible benefits of vitamin D₃ supplementationIncreased oxidative stress and altered substrate metabolism in obese children.Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.Acarbose reduces blood glucose by activating miR-10a-5p and miR-664 in diabetic ratsThe interleukin-6 and noradrenaline mediated inflammation-stress feedback mechanism is dysregulated in metabolic syndrome: effect of exercise.The gp130 receptor cytokine family: regulators of adipocyte development and function.
P2860
Q24630117-9DFFB69F-F860-4E54-80F4-A6CCE3A6DEE1Q26744385-76F8318C-A6F0-44B6-96BB-7AEB6702B46BQ26780254-D8409AED-4E52-48DB-A80A-6185BD33E04BQ26785313-8A432B76-92D4-482F-A221-35C3608D1964Q26860579-3D9966F1-F17B-4D9E-8D7D-A430AD0111B9Q27005951-D790113D-2C31-45AD-B776-55DF2A5FA0BFQ27012497-147D75E3-4F29-4D20-844A-C6224DF1215FQ28073309-9CA1BEC6-516D-4338-8BBA-D498DD97A52BQ28270969-89CEE7B5-B637-48A8-A71D-A161A11DBF80Q28534691-EE70CCCA-2E83-425F-B4F8-15CFB3613234Q28740387-B1D6208F-ED8D-4D03-8591-6D94F466EA61Q28744267-7F605A39-C1F9-4ADF-8E3E-97CAAE20E641Q30410968-A8315C30-D487-449B-9DCC-74C2E19EE34BQ30426181-5096B80F-FFF5-4CA7-A050-230D54EA20EDQ30462675-6AE6D1DC-3F2F-4226-9870-56DDB9C5C225Q31132948-24E0CA56-3D77-484C-990E-7B55288DF809Q33364177-9FDCF13D-33EE-49BC-B14D-867BFA049CD4Q33442137-AC3C1B37-2DEA-4CAE-AE50-F32EE29451A8Q33656668-C4D6B6B0-673D-4F74-B3C0-47D6E2BBBAE7Q33751519-2B0D9774-5939-418A-A9F5-1BC1CF383C42Q33821861-072343DE-B12C-41B0-92EC-456751DF7D76Q33837077-C01537E6-7EC5-4D2E-9E3B-0F12C64D8E31Q33986074-D46DB573-4412-4991-A12D-CD462BF8A11EQ34023565-5153A1EE-5640-49F4-9604-4D0C7FEA8A7FQ34025142-3860F26A-6D9A-4C94-883F-E5E05C9260DBQ34084611-E6D71828-07D4-4227-B619-DD54F6A79C8EQ34153905-28BC2371-070E-4565-B356-51677AD15C95Q34355278-6739ECBB-FC7A-4EC3-A923-CBF7CC8163D2Q34477570-CB12D818-28A1-441B-A672-74102C6D1463Q34567797-BDDFABC4-E9ED-471D-A035-A307CFD15A1CQ34574670-ADCF799B-167F-405E-80A3-0A9C475CEE19Q34619801-2C537393-9158-4901-93D3-14565048BA93Q34620441-1EC47A24-DAC7-4C92-A789-5300EEA7786EQ34700576-6AABA6F0-3729-4837-836A-27C34D8EA999Q34907819-B7123DCD-A69A-4894-9AC9-1A6102AF8E50Q35033244-3B3C27E8-8E34-4464-9910-5A9F0E728226Q35043902-AF8A34B0-6F74-4443-A612-479FD8EDD3B1Q35048656-6DF9D180-7B99-4A64-AA89-BEF53C21310BQ35054609-EB026EA9-1367-42AD-9B46-007D95A2EBDFQ35059389-CA384E01-F9D6-44D7-94D9-263872EE3931
P2860
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@ast
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@en
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@nl
type
label
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@ast
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@en
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@nl
prefLabel
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@ast
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@en
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@nl
P1433
P1476
Interleukin-6 and diabetes: the good, the bad, or the indifferent?
@en
P2093
Ole P Kristiansen
P304
P356
10.2337/DIABETES.54.SUPPL_2.S114
P407
P478
54 Suppl 2
P577
2005-12-01T00:00:00Z